Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-06

Clinical Trial Update: Evaluation of MG53 (TRIM72) Levels in Women With Polycystic Ovary Syndrome: An Observational Study

View source ↗

Summary

An observational study evaluating MG53 (TRIM72) levels in women with polycystic ovary syndrome (PCOS), including participants with insulin resistance, and curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Havva Betül Bacak | Conditions: Polycystic Ovary Syndrome (PCOS), Insulin Resistance Syndrome | Status: ENROLLING_BY_INVITATION